Humanized anti-CD4 antibody with immunosuppressive properties
US7452981B2 · kind B2 · utility
75Cited by
1References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 2, 2005 |
| Grant date | Nov 18, 2008 |
| Priority date | — |
| Expiry date | Sep 2, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/73
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A humanized antibody derived from mouse monoclonal anti-CD4 antibody B-F5 is able to activate CD25+CD4+ regulatory T cells and is useful for preparing immunosuppressive compositions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.